Skip to content
OpenCapital
Get started

BioCardia, Inc. BCDA Q4 2024 Annual earnings

Reported March 26, 2025 · After market close

Revenue$25.0KBeat by $2.5KDiluted EPS-$0.25Beat by $0.62
Revenue estimate$22.5K
EPS estimate-$0.87

Next report

Aug 10, 2026 (In 4 weeks)
EPS estimate-$0.19

Versus estimates

Revenue

Q4 2024$25.0KBeat by $2.5K

Diluted EPS

Q1 2026-$0.21Miss by $0.04Q4 2025-$0.06Beat by $0.14Q3 2025-$0.24Beat by $0.01Q2 2025-$0.40Miss by $0.15Q1 2025-$0.59Miss by $0.20
Q4 2024-$0.25Beat by $0.62

Ask the moment BioCardia, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioCardia, Inc. report Q4 2024 earnings?
BioCardia, Inc. (BCDA) reported Q4 2024 earnings on March 26, 2025 after market close.
What were BioCardia, Inc.'s Q4 2024 revenue and EPS?
BioCardia, Inc. reported revenue of $25.0K and diluted EPS of $-0.25 for Q4 2024.
Did BioCardia, Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $22.5K by $2.5K. EPS beat the consensus estimate of $-0.87 by $0.62.
Where can I find BioCardia, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001437749-25-009397) directly on SEC EDGAR. The filing index links above go to sec.gov.